吉林建邦医药科技开发

吉林建邦医药科技开发有限公司 (Jilin Jianbang Pharmaceutical Technology Development Co., Ltd.) is a Chinese biopharmaceutical research and development company based in Jilin Province. Led by prominent scientist Li Pingya, a professor at Jilin University and foreign academician of the Russian Academy of Natural Sciences, the company focuses on the research, development, and commercialization of natural products, traditional Chinese medicines, and botanical extracts. Its core scientific expertise lies in the structural modification, activity screening, and metabolic profiling of ginsenosides and other saponins. The company has developed several innovative drug candidates, including pseudo-ginsenoside GQ injection for cardiovascular diseases and Yangshengguo Guanxin tablets.